News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,937 Results
Type
Article (41629)
Company Profile (261)
Press Release (650047)
Section
Business (206850)
Career Advice (1996)
Deals (35921)
Drug Delivery (79)
Drug Development (81043)
Employer Resources (167)
FDA (16227)
Job Trends (14957)
News (348580)
Policy (32868)
Tag
Academia (2602)
Africa (733)
Alliances (50213)
Alzheimer's disease (1165)
Approvals (16148)
Arizona (176)
Artificial intelligence (71)
Asia (37947)
Australia (6181)
Bankruptcy (354)
Best Places to Work (11368)
Biosimilars (63)
Biotechnology (181)
C2C Services and Suppliers (81585)
California (1900)
Canada (943)
Cancer (494)
Career advice (1666)
Cell therapy (121)
China (151)
Clinical research (63479)
Collaboration (140)
Colorado (81)
Compensation (81)
Connecticut (75)
COVID-19 (2516)
Cystic fibrosis (75)
Data (313)
Diabetes (81)
Diagnostics (6349)
Drug pricing (63)
Earnings (84532)
Employer resources (142)
Europe (81950)
Events (109347)
Executive appointments (155)
FDA (16456)
Florida (267)
Funding (149)
Gene therapy (93)
Georgia (65)
GLP-1 (514)
Government (4349)
Healthcare (18843)
Hotbed/Location (486856)
Illinois (262)
Indiana (151)
Infectious disease (2545)
Inflammatory bowel disease (91)
Interviews (308)
IPO (16376)
Job creations (3714)
Job search strategy (1431)
Kansas (97)
Layoffs (397)
Legal (7918)
Lung cancer (111)
Manufacturing (87)
Maryland (400)
Massachusetts (1538)
Medical device (13196)
Medtech (13201)
Mergers & acquisitions (19414)
Metabolic disorders (249)
Michigan (124)
Minnesota (222)
Neuroscience (1313)
New Jersey (585)
New York (599)
NextGen Class of 2024 (6541)
Non-profit (4525)
North Carolina (624)
Northern California (827)
Obesity (148)
Ohio (104)
Opinion (172)
Patents (75)
Pennsylvania (582)
People (56743)
Phase I (19674)
Phase II (27962)
Phase III (20867)
Pipeline (112)
Postmarket research (2560)
Preclinical (8414)
Press Release (66)
Rare diseases (132)
Real estate (6027)
Recruiting (63)
Regulatory (21523)
Research institute (2364)
Resumes & cover letters (348)
South America (1114)
Southern California (771)
Startups (3657)
Texas (243)
United States (8677)
Vaccines (475)
Washington State (257)
Weight loss (128)
Date
Today (121)
Last 7 days (645)
Last 30 days (2462)
Last 365 days (37542)
2024 (26493)
2023 (40505)
2022 (51627)
2021 (56204)
2020 (54703)
2019 (47112)
2018 (35523)
2017 (32722)
2016 (32215)
2015 (38336)
2014 (32054)
2013 (27200)
2012 (29429)
2011 (30115)
2010 (28017)
691,937 Results for "hitachi chemical diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
Roche announced that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration.
May 27, 2024
·
5 min read
RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system
RaySearch Laboratories AB (publ) is pleased to announce a milestone in radiotherapy technology where RaySearch’s RayStation®* was used for the world’s first clinical treatment using OXRAY, a new treatment machine from Hitachi.
June 18, 2024
·
3 min read
Press Releases
Hitachi High-Tech Acquires Majority Interest in Nabsys
August 2, 2024
·
4 min read
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com.
June 6, 2024
·
2 min read
Press Releases
Bioz Announces a New Partnership With Hitachi High-Tech Enabling Real-Time Access to Scientific Citation Data
August 20, 2024
·
2 min read
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company has been invited to participate in the Utah booth at the FIME trade show in Miami Beach, Florida, on June 19-21.
June 18, 2024
·
1 min read
Business
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.
May 9, 2024
·
10 min read
Biotech Bay
Hitachi Chemical Diagnostics Renamed Minaris Medical America
Effective July 1, 2021 local time, Hitachi Chemical Diagnostics, Inc. is renamed to Minaris Medical America, Inc. and its group company Hitachi Chemical Diagnostics Systems Co., Ltd. is renamed to Minaris Medical Co., Ltd.
July 1, 2021
·
1 min read
Business
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the market close.
April 25, 2024
·
1 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
1 of 69,194
Next
